Anti-Calnexin antibody [EPR3632] - BSA and Azide free
- RabMAb
- Recombinant
- KO Validated
- What is this?
0
(1 Review)
|
(2 Publications)
Rabbit Recombinant Monoclonal Calnexin antibody. Carrier free. Suitable for IHC-P, IP, WB, ICC/IF and reacts with Human samples. Cited in 2 publications.
View Alternative Names
Calnexin, IP90, Major histocompatibility complex class I antigen-binding protein p88, p90, CANX
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Calnexin antibody [EPR3632] - BSA and Azide free (AB232433)
ab92573 staining Calnexin in wild-type HAP1 cells (top panel) and CANX knockout HAP1 cells (bottom panel). The cells were fixed with 100% methanol (5min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab92573 at 1/1000 dilution and ab195889 at 1/250 dilution (shown in pseudocolour red) overnight at +4°C, followed by a further incubation at room temperature for 1h with a goat secondary antibody to Rabbit IgG (Alexa Fluor® 488) (ab150081) at 2 μg/ml (shown in green). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab92573).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Calnexin antibody [EPR3632] - BSA and Azide free (AB232433)
Immunohistochemical analysis of paraffin embedded Human tonsil tissue using ab92573 at a 1/100 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab92573).
- IP
Lab
Immunoprecipitation - Anti-Calnexin antibody [EPR3632] - BSA and Azide free (AB232433)
This data was developed using ab92573, the same antibody clone in a different buffer formulation.
Calnexin was immunoprecipitated from 0.35 mg HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate 10 µg with ab92573 at 1/100 dilution (2µg). VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate 10 µg
Lane 2 : ab92573 IP in HeLa whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab92573 in HeLa whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-Calnexin antibody [EPR3632] (<a href='/en-us/products/primary-antibodies/calnexin-antibody-epr3632-ab92573'>ab92573</a>)
Predicted band size: 68 kDa
Observed band size: 90 kDa
false
- WB
Lab
Western blot - Anti-Calnexin antibody [EPR3632] - BSA and Azide free (AB232433)
This data was developed using the same antibody clone in a different buffer formulation (ab92573).
Lanes 1 - 4 : Merged signal (red and green). Green - ab92573 observed at 80 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37 kDa.
ab92573 was shown to react with Calnexin in wild-type HEK-293T cells in Western blot with loss of signal observed in CANX knockout cell line ab255368 (CANX knockout cell lysate ab263805). Wild-type HEK-293T and CANX knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab92573 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4 °C at a 1 in 20000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-Calnexin antibody [EPR3632] (<a href='/en-us/products/primary-antibodies/calnexin-antibody-epr3632-ab92573'>ab92573</a>) at 1/20000 dilution
Lane 1:
Wild-type HEK-293T cell lysate at 20 µg
Lane 2:
CANX knockout HEK-293T cell lysate at 20 µg
Lane 2:
Western blot - Human CANX (Calnexin) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-canx-calnexin-knockout-hek-293t-cell-line-ab255368'>ab255368</a>)
Lane 3:
U-2 OS cell lysate at 20 µg
Lane 4:
MCF7 cell lysate at 20 µg
Predicted band size: 68 kDa
Observed band size: 80 kDa
false
- WB
Supplier Data
Western blot - Anti-Calnexin antibody [EPR3632] - BSA and Azide free (AB232433)
Lanes 1 - 4 : Merged signal (red and green). Green - ab92573 observed at 80 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab92573 was shown to specifically react with Calnexin when Calnexin knockout samples were used. Wild-type and Calnexin knockout samples were subjected to SDS-PAGE. ab92573 and ab8245 (loading control to GAPDH) were diluted at 1/20,000 and 1/10,000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776 secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab92573).
All lanes:
Western blot - Anti-Calnexin antibody [EPR3632] (<a href='/en-us/products/primary-antibodies/calnexin-antibody-epr3632-ab92573'>ab92573</a>) at 1/20000 dilution
Lane 1:
Wild-type HAP1 cell lysate at 20 µg
Lane 2:
Calnexin knockout HAP1 cell lysate at 20 µg
Lane 3:
THP-1 cell lysate at 20 µg
Lane 4:
RAW 264.7 cell lysate at 20 µg
Predicted band size: 68 kDa
false
Related conjugates and formulations (8)
-
Anti-Calnexin antibody [EPR3632]
-
660 APC
APC Anti-Calnexin antibody [EPR3632]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Calnexin antibody [EPR3632]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Calnexin antibody [EPR3632]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Calnexin antibody [EPR3632]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Calnexin antibody [EPR3632]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-Calnexin antibody [EPR3632]
-
578 PE
PE Anti-Calnexin antibody [EPR3632]
Reactivity data
Product details
ab232433 is the carrier-free version of ab92573.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Calnexin facilitates the proper folding of newly synthesized proteins by forming a complex with another chaperone protein called ERp57. This interaction helps in creating the correct disulfide bonds in glycoproteins which is essential for their stability and functionality. The complex often referred to as the calnexin cycle is critical in preventing the aggregation and misfolding of proteins within the ER. This process ensures that only correctly folded proteins proceed to the Golgi apparatus for further processing and transport.
Pathways
Calnexin plays an important role in the ER-associated degradation (ERAD) pathway and the unfolded protein response (UPR). In these pathways calnexin ensures that misfolded proteins are retained in the ER or targeted for degradation preventing cellular stress. Calnexin is associated with proteins such as calreticulin another chaperone protein with a similar function in the ER. Together they maintain proteostasis within cells and protect against the accumulation of improperly folded proteins.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Cellular and molecular gastroenterology and hepatology 12:395-425 PubMed33676046
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 11:352 PubMed32210961
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com